Clinical trial
Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00054808 · Genta Incorporated, Industry · Completed
Key facts
| NCT number | NCT00054808 |
|---|---|
| Title | Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma |
| Official title | A Phase II Multicenter Study of Gallium Nitrate in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma |
| Lead sponsor | Genta Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Relapsed Lymphoma, Refractory Lymphoma, Low-Grade Lymphoma, Intermediate-Grade Lymphoma |
| Intervention type | Drug |
| Interventions | gallium nitrate |
| Enrollment | 40 |
| Start date | Jun 1, 2002 |
| First posted | Feb 13, 2003 |
| Last update posted | Feb 8, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: